Medications

New drug molecule for treatment of atrial fibrillation

Scientists from the National University of Singapore (NUS) Department of Pharmacy have developed an improved pharmaceutical drug for the treatment of the most common heart rhythm disturbance—atrial fibrillation (AF). The ...

Diseases, Conditions, Syndromes

What heart and stroke patients need to know about COVID-19 in 2022

Two years into the pandemic, researchers have learned a lot about how COVID-19 affects people with heart disease and stroke survivors. But like the coronavirus itself, what everyone needs to know keeps evolving.

Diseases, Conditions, Syndromes

Rethink what you thought you knew about COVID-19 reinfection

Forget what you thought you knew about catching COVID-19 more than once. SARS-CoV-2, the virus that causes COVID-19, keeps evolving—and so has information about your risk of being reinfected.

page 2 from 40